# A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo

> **NCT02172001** · PHASE3 · WITHDRAWN · sponsor: **Pharmacosmos A/S**

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Iron isomaltoside 1000
- **DRUG:** Natrium Chloride 0,9%

## Key facts

- **NCT ID:** NCT02172001
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2015-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study design not adequate
- **Last updated:** 2016-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02172001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02172001, "A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02172001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*